ITF Pharma Announces FDA Approval of Tiglutik (riluzole) Oral Suspension for the Treatment of Amyotrophic Lateral Sclerosis (ALS) BERWYN, Pa., Sept. 6, 2018 /PRNewswire/ — ITF Pharma, a U.S.-based specialty pharmaceutical company and a subsidiary of Italfarmaco, a privately-held European specialty pharmaceutical company, committed to investing in and commercializing impactful medicines in therapeutic areas with […]Continue Reading ...
A mechanism for how the disease ALS evolves has been discovered at Umeå University, Sweden. The discovery concerns how proteins with a defect structure spread the deformation to other proteins. This according to results in a new thesis. The discovery can open up for novel pharmaceutical developments in the future. “We’ve been able to identify […]Continue Reading ...
August 20, 2018 ALS — amyotrophic lateral sclerosis — is a neurodegenerative disease that attacks motor neurons in the brain and spinal cord, slowly robbing its victims of their ability to walk, talk, breathe and swallow. In a cruel twist, some ALS patients also develop frontotemporal dementia, a disease that destroys an entirely different set […]Continue Reading ...
Robert Bucelli, MD, PhD, measures Gregory Easter’s neuromuscular function. Easter, who has an inherited form of amytrophic lateral sclerosis, a fatal neuromuscular disease, is taking part in a clinical trial to evaluate an experimental drug. New research at Washington University School of Medicine in St. Louis shows the drug extends survival and reverses some neuromuscular […]Continue Reading ...
July 12, 2018 Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig’s disease, according to a new study out of Case Western Reserve University School of Medicine. Researchers found high levels of the protein–called mitofusion 2 or Mfn2–prevented nerve degeneration, muscle atrophy, and paralysis in a mouse model […]Continue Reading ...
An MRI with increased signal in the posterior part of the internal capsule which can be tracked to the motor cortex consistent with the diagnosis of ALS. Credit: Frank Gaillard/Wikipedia Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring […]Continue Reading ...
MONDAY, June 4, 2018 — A new immunotherapy appears to be well tolerated and possibly of benefit in patients with amyotrophic lateral sclerosis (ALS), according to a phase 1, first-in-human study published online May 18 in Neurology: Neuroimmunology & Neuroinflammation. Jason R. Thonhoff, M.D., Ph.D., from the Houston Methodist Neurological Institute, and colleagues assessed the […]Continue Reading ...
May 25, 2018 As the old adage goes, ‘two heads are better than one’. With the development of new technologies and increasingly specialist expertise, ground-breaking science needs to be a team effort. But it isn’t always easy for researchers to work together. Finding the right people to collaborate with can be tricky, especially when some […]Continue Reading ...
Copenhagen, August 10, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced that the first patient has received the first dose in its Phase III clinical trial of arimoclomol for Amyotrophic Lateral Sclerosis (ALS). Thomas Blaettler, Chief Medical Officer, said: “The enrollment of the first […]Continue Reading ...
July 27, 2018 NIH-funded researchers delayed signs of amyotrophic lateral sclerosis (ALS) in rodents by injecting them with a second-generation drug designed to silence the gene, superoxide dismutase 1 (SOD1). The results, published in the Journal of Clinical Investigation, suggest the newer version of the drug may be effective at treating an inherited form of […]Continue Reading ...
July 19, 2018 The mutated and aggregated protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers led by prof. Ludo Van Den Bosch (VIB-KU Leuven) have zoomed in on the protein structure of FUS to gain more insight into […]Continue Reading ...
ALS patient motor neurons obtained through optopatch recordings. Credit: Northwestern University Northwestern Medicine scientists have discovered that some neurons affected by amyotrophic lateral sclerosis (ALS) display hypo-excitability, using a new method to measure electrical activity in cells, according to a study published in Stem Cell Reports. “The excitability changes observed in these patient neurons most […]Continue Reading ...
June 21, 2018 Aquinnah Pharmaceuticals, leaders in stress granule biology, an exciting new target for the development of neurodegenerative therapeutics, announced today that it has been awarded $3.4 million from the National Institute of Neurological Disorders and Stroke (NINDS) in a competing grant to advance novel therapeutic drug candidates towards the clinic for treating patients […]Continue Reading ...
May 23, 2018 Scientists have just discovered that a small region of a cellular protein that helps long-term memories form also drives the neurodegeneration seen in Amyotrophic Lateral Sclerosis (ALS). This small part of the Ataxin-2 protein thus works for good and for bad. When a version of the protein lacking this region was substituted […]Continue Reading ...
May 23, 2018 A new Tel Aviv University study identifies a previously unknown mechanism involved in the development of Lou Gehrig’s disease, or amyotrophic lateral sclerosis (ALS). The research focuses on a specific microRNA whose levels were found to decrease as a result of ALS-causing muscular mutations. The study highlights, for the first time, the […]Continue Reading ...
- UK and European research collaborations receive vote of confidence by three major cancer charities
- Microbiota in the intestines and cell stress cause colon cancer
- Arizona EMTs have 39% higher risk for suicide than general public
- Driving and older adults: MedlinePlus Medical Encyclopedia
- Researchers test autobiographical memory for early Alzheimer’s detection
- Organizations join forces to help teens with severe mental health challenges | News Center
- Neurons in the human brain can encode numerical information
- Potential drugs to treat neurodegenerative diseases garner $3 million grant
- Processing speed important to higher order cognitive function in multiple sclerosis patients
- Helping a patient survive a hurricane
- Tafamidis Treats Transthyretin Amyloid Cardiomyopathy
- Low academic achievement can lead to drug abuse decades later, research finds
- Study identifies stem cell that gives rise to new bone, cartilage in humans | News Center
- Celltrion and Emory University sign ‘Incubation’ agreement to develop new drug candidates for atherosclerosis
- TGen and PNOC take part in launch of NIH-supported Kids First Data Resource Portal
- Could Household Cleaners Make Your Kid Fat?
- Addiction nonprofit makes searching for services simple
- We are bombarded by thousands of diverse species and chemicals | News Center
- Experts to Present Prostate Cancer Advances at Patient Summit
- Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia